MedPath
HSA Approval

BETASERC 24 TABLET 24 mg

SIN12235P

BETASERC 24 TABLET 24 mg

BETASERC 24 TABLET 24 mg

March 24, 2003

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence HolderABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N07CA01

betahistine

Manufacturer Information

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Mylan Laboratories SAS

Active Ingredients

BETAHISTINE 2HCl

24 mg

Betahistine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.